US-based clinical service company WCG has acquired Trifecta Clinical, a provider of technology-enabled clinical trial solutions for an undisclosed price.

The acquisition includes Trifecta Clinical’s site communication platform InvestigatorSpace, virtual training programs, and also safety documentation services.

WCG provides solutions for improving the quality and efficiency of clinical research.

The acquisition of Trifecta will expand the variety of specialized services and solutions offered by WCG. Besides, it will improve WCG’s ability to connect sites, sponsors, and clinical research organizations (CROs) across the clinical trials ecosystem.

Donald A. Deieso – Executive Chairman and CEO of WCG said: “With a host of services that fully integrate clinical trial training and communication, from safety letter notification to regulatory document exchange, Trifecta adds another dimension to WCG’s compelling value proposition.

“This acquisition is part of our effort to pursue strategic opportunities that allow us to expand and enhance our offerings in anticipation of our customers’ needs. We’re pleased to be joining forces with an innovative company such as Trifecta and working together to help sponsors, CROs, and clinical research sites increase efficiency and the quality of the work they do every day.”

Going forward, Trifecta Clinical will operate as WCG Trifecta. Its leadership structure will be retained along with its headquarters located in Los Angeles, and its other locations in Indianapolis, Philadelphia, and Osaka, Japan.

Dave Young – Trifecta Clinical Founder and CEO said: “We’re thrilled to be joining WCG, a company that shares our passion for improving the clinical trial process by delivering impactful solutions to age-old problems. This acquisition was a natural evolution for Trifecta. Now as part of WCG, we can help our customers by continuing to provide perpetual innovation, rooted in unrivaled expertise.”

  Dave Young, Donald A. Deieso, Trifecta Clinical, USA, WCG